Replies to post #100555 on Biotech Values

[genisi]

If Teva were approved tomorrow, the downside would be a lot lower than $18/share. Of course that's not going to happen.

That didn't happen, tomorrow is today :) kidding aside, if "tomorrow" is the next few weeks like Teva thinks, I suppose downside would still be a lot lower than $18/share. Agree?